Opportunistic Infections in Patients with and Patients without Acquired Immunodeficiency Syndrome
Author(s) -
Kent A. Sepkowitz
Publication year - 2002
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/339548
Subject(s) - medicine , pneumocystis carinii , cryptococcosis , pneumonia , immunology , opportunistic infection , population , epidemiology , immunodeficiency , immunopathology , aids related opportunistic infections , cytomegalovirus , pneumocystis jirovecii , immune system , human immunodeficiency virus (hiv) , intensive care medicine , sida , viral disease , herpesviridae , environmental health
In the next decade, longer survival of patients with cancer and more-aggressive therapies applied to common conditions, such as asthma and rheumatoid arthritis, will result in a larger population with significant immune system defects. Many in this population will be at risk for opportunistic infections, which are familiar to doctors who have treated people infected with human immunodeficiency virus (HIV). However, the epidemiology, presentation, and outcome of these infections in patients with an immune system defect, other than that caused by HIV infection, may be different than those encountered in patients with acquired immunodeficiency syndrome. Reviewed are 4 common opportunistic infections: Pneumocystis carinii pneumonia, cryptococcosis, atypical mycobacterial infection, and cytomegalovirus infection. Emphasized are the important differences among these groups at risk.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom